Malignant prolactinoma discovered by D2 receptor imaging.
Petrossians
P
P
Department of Endocrinology, University Hospital, Liege, Belgium.
de Herder
W
W
Kwekkeboom
D
D
Lamberigts
G
G
Stevenaert
A
A
Beckers
A
A
D000328:Adult; D001549:Benzamides; D003287:Contrast Media; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes; D008279:Magnetic Resonance Imaging; D008297:Male; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism; D015175:Prolactinoma / Q000000981:diagnostic imaging* / Q000378:metabolism; D011759:Pyrrolidines; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2 / Q000378:metabolism*
D001549:Benzamides; D003287:Contrast Media; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2; C063525:epidepride